We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Oncology

Journal Scan / Research · February 10, 2021

4 Gy Versus 24 Gy Radiotherapy for Follicular and Marginal Zone Lymphoma

The Lancet Oncology

 

Save Recommend
Share

Additional Info

Disclosure statements are available on the authors' profiles:

Paul Hampel MD

The Lancet Oncology
4 Gy Versus 24 Gy Radiotherapy for Follicular and Marginal Zone Lymphoma (FoRT): Long-Term Follow-Up of a Multicentre, Randomised, Phase 3, Non-Inferiority Trial
Lancet Oncol 2021 Feb 01;[EPub Ahead of Print], P Hoskin, B Popova, O Schofield, C Brammer, M Robinson, AM Brunt, K Madhavan, T Illidge, E Gallop-Evans, I Syndikus, L Clifton-Hadley, AA Kirkwood

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated